<?xml version='1.0' encoding='utf-8'?>
<resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'>
<creators>
<creator>
<creatorName>Ghinda, S..</creatorName>
<affiliation>IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc“, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Rudic, V.F.</creatorName>
<affiliation>Institutul de Microbiologie şi Biotehnologie al AŞM, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Sofroni, D.T.</creatorName>
<affiliation>IMSP Institutul Oncologic, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Clipca, I.</creatorName>
<affiliation>IMSP Institutul Oncologic, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Chiriac, T.V.</creatorName>
<affiliation>Institutul de Microbiologie şi Biotehnologie al AŞM, Moldova, Republica</affiliation>
</creator>
<creator>
<creatorName>Rotaru, N.I.</creatorName>
<affiliation>IMSP Institutul de Ftiziopneumologie „Chiril Draganiuc“, Moldova, Republica</affiliation>
</creator>
</creators>
<titles>
<title xml:lang='ro'>Acţiunea preparatului bior asupra reactivităţii imunologice la pacientele cu cancer mamar
</title>
</titles>
<publisher>Instrumentul Bibliometric National</publisher>
<publicationYear>2010</publicationYear>
<relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1857-0011</relatedIdentifier>
<dates>
<date dateType='Issued'>2010-09-01</date>
</dates>
<resourceType resourceTypeGeneral='Text'>Journal article</resourceType>
<descriptions>
<description xml:lang='ro' descriptionType='Abstract'>Studiul a inclus 19 paciente, divizate în două grupuri: а) de bază – 13 paciente, supuse chimioterapiei în combinaţie
cu preparatul BioR (în total 27 de cure de tratament) şi b) grupul martor – 6 paciente, care au fost supuse numai chimioterapiei
(în total 8 cure de tratament). Analiza reactivităţii imunologice la pacientele cu cancer mamar denotă prezenţa
dereglărilor pronunţate, atât ale indicilor imunităţii celulare, cât şi ale indicilor imunităţii umorale. La co-administrarea
preparatului BioR în cadrul chimioterapiei, la majoritatea pacientelor se determină un efect clinic pozitiv asupra indicilor
studiaţi faţă de pacientele supuse doar regimului de chimioterapie.</description>
<description xml:lang='en' descriptionType='Abstract'>The study was based on 19 patients divided into two groups: а) basic - 13 patients subjected to chemotherapy in
combination with BioR (total of 27 treatment courses) and b) control group - 6 patients who have undergone chemotherapy
only (total 8 courses of treatment). Analysis of immunological reactivity of patients with breast cancer indicates the
presence of pronounced disturbances, both of cellular immunity of humoral immunity indices. When BioR was administered
in conjunction with chemotherapy, a positive clinical effect on the indices was observed, in comparison to the
patients who only took chemotherapy.</description>
</descriptions>
<formats>
<format>application/pdf</format>
</formats>
</resource>